Serum microRNA screening and functional studies reveal miR-483-5p as a potential driver of fibrosis in systemic sclerosis

Eleni Chouri; Nila H. Servaas; Cornelis P. J. Bekker; Alsya J. Affandi; Marta Cossu; Maarten R. Hillen; Chiara Angiolilli; Jorre S. Mertens; Lucas L. van den Hoogen; Sandra C. Silva‐Cardoso; Maarten van der Kroef; Nadia Vazirpanah; Catharina G. K. Wichers; Tiago Carvalheiro; Sofie L. M. Blokland; Barbara Giovannone; Laura Porretti; Wioleta Marut; Barbara Vigone; Joël A. G. van Roon; Lorenzo Beretta; Marzia Rossato; Timothy R. D. J. Radstake

doi:10.1016/j.jaut.2017.12.015

Abstract

Our findings showed that miR-483-5p is up-regulated in the serum of SSc patients, from the early stages of the disease onwards, and indicated its potential function as a fine regulator of fibrosis in SSc.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Chouri et al. (2018) studied this question.

synapsesocial.com/papers/69da25f694a959ed41a3c0d8 https://doi.org/10.1016/j.jaut.2017.12.015

View Full Paper

Ask AI

Bookmark

Share

Serum microRNA screening and functional studies reveal miR-483-5p as a potential driver of fibrosis in systemic sclerosis

Abstract

Discussion

Cite This Study

Serum microRNA screening and functional studies reveal miR-483-5p as a potential driver of fibrosis in systemic sclerosis

Abstract

Discussion

Cite This Study

Keep reading

Keep reading